Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Int J Clin Pract. 2021 Mar;75(3):e13799. doi: 10.1111/ijcp.13799. Epub 2020 Nov 20.
Arteriovenous access (AV) thrombosis is an important and preventable problem amongst chronic hemodialysis (HD) patients. Systolic blood pressure (SBP) fluctuation relates to higher cardiovascular mortality amongst these patients. We proposed there is a close relation between SBP changes and arteriovenous (AV) access thrombosis. We also determined other risk factors and biochemical parameters related to AV access failure.
50 HD patients with thrombosis and 50 HD patients without thrombosis were included in the study. Odds ratios and 95% confidence intervals were estimated with multivariate-adjusted logistic regression models to determine the association between potential thrombosis-related risk factors and thrombosis risk.
Elder adults, women, and patients with AV grafts, lower intradialytic SBP and higher SBP variations during HD sessions had higher incidence of AV access thrombosis. AV access infection and decreased blood flow (BF) velocity were associated with an increased incidence of thrombotic events, whereas the use of anti-thrombotic agents was associated with a decreased incidence of thrombotic events. Further, anaemia, hypoalbuminemia, hyperlipidemia, and impaired mineral metabolism parameters were also found to be associated with AV access thrombosis.
Close monitoring and management of intradialytic hypotension and SBP fluctuation in every HD session are important. Some important and novel modifiable risk factors related to AV access thrombosis were identified in this study (eg, AV access infection, decreased BF and abnormal biochemical parameters, etc). Earlier surveillance and modification of these risk factors is crucial to prevent AV access failure in HD patients.
动静脉内瘘(AV)血栓形成是慢性血液透析(HD)患者的一个重要且可预防的问题。这些患者的收缩压(SBP)波动与更高的心血管死亡率有关。我们提出 SBP 变化与动静脉(AV)内瘘血栓形成之间存在密切关系。我们还确定了与 AV 内瘘失败相关的其他风险因素和生化参数。
研究纳入了 50 例血栓形成的 HD 患者和 50 例无血栓形成的 HD 患者。采用多变量调整的逻辑回归模型估计比值比和 95%置信区间,以确定潜在的血栓形成相关风险因素与血栓形成风险之间的关联。
老年人、女性和 AV 移植物患者、透析期间较低的透析内 SBP 和更高的 SBP 变化率,其 AV 内瘘血栓形成发生率较高。AV 内瘘感染和血流量(BF)降低与血栓形成事件发生率增加相关,而使用抗血栓形成药物与血栓形成事件发生率降低相关。此外,贫血、低白蛋白血症、高脂血症和矿物质代谢参数异常也与 AV 内瘘血栓形成有关。
密切监测和管理每次 HD 期间的透析内低血压和 SBP 波动非常重要。本研究确定了一些与 AV 内瘘血栓形成相关的重要且新颖的可改变风险因素(例如,AV 内瘘感染、BF 降低和异常生化参数等)。早期监测和修改这些风险因素对于预防 HD 患者的 AV 内瘘失败至关重要。